Geisinger CEO hired by Google to oversee healthcare push

Amy Baxter | November 09, 2018 | Health Exec |

Google has taken another prominent healthcare executive under its roof to oversee the company’s own healthcare initiatives, The Wall Street Journal reported.

David Feinberg, MD, who has served as president and CEO of Geisinger Health System since 2015, has been named to a newly created leadership role at Google. Geisinger, based in Danville, Pennsylvania, is a healthcare system that operates 13 hospital campuses and a health plan with nearly 600,000 members. It serves more than 1.5 million patients in Pennsylvania and New Jersey.

Jaewon Ryu, MD, JD, will act as interim president and CEO of Geisinger starting Dec. 1, 2018, Geisinger announced.

Google’s latest hire continues the company’s emergence in the healthcare space. Google is reportedly working on an AI-powered wellness app, among other initiatives. Google’s parent company Alphabet has also invested hundreds of millions of dollars in healthcare startups, including health insurer Oscar Health.

Feinberg will help provide strategic direction for Google's ongoing healthcare pushes, the WSJ reported.

See the full story below:

Google Picks Geisinger CEO to Oversee Health-Care Initiatives

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."